2 min read Politics Brokerages Boost MoonLake Immunotherapeutics Price Target to $74.50 Editorial 11 July, 2025 Shares of MoonLake Immunotherapeutics (NASDAQ:MLTX) have received a consensus rating of “Buy” from seven...Read More
